Cargando…
Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections
The prevalence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae urinary tract infections (UTIs) is increasing worldwide. We investigated the prevalence, clinical findings, impact and risk factors of ESBL E. coli/K. pneumoniae UTI through a retrospective...
Autores principales: | Vachvanichsanong, P., McNeil, E. B., Dissaneewate, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057452/ https://www.ncbi.nlm.nih.gov/pubmed/33327984 http://dx.doi.org/10.1017/S0950268820003015 |
Ejemplares similares
-
Analysis of drug resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in children with urinary tract infection
por: Keshi, Lu, et al.
Publicado: (2019) -
Efficacy of cefoxitin for the treatment of urinary tract infection
due to extended-spectrum-beta-lactamase-producing Escherichia
coli and Klebsiella pneumoniae
isolates
por: Senard, Olivia, et al.
Publicado: (2018) -
Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
por: Tulara, Neeraj Kumar
Publicado: (2018) -
In Vitro Efficacy of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Associated with Urinary Tract Infections in Malaysia
por: Ngoi, Soo Tein, et al.
Publicado: (2021) -
Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
por: Han, Seung Beom, et al.
Publicado: (2015)